CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 20 No. 8
Pages: 1  2  
Next
BOOK REVIEW 

Integrative Oncology: Principles and Practice

By

Reviewed by
Donald I. Abrams, MD
Chief, Hematology-Oncology
San Francisco General Hospital
Osher Center for
Integrative Medicine
UCSF Comprehensive
Cancer Center
University of California,
San Francisco
San Francisco, California

| July 1, 2006

Editor: Matthew P. Mumber, MD
Publisher: Taylor & Francis,
London and New York
517 pages
Cost: $149.95


The emerging field of integrative oncology now has a definitive textbook, thanks to the Herculean effort of Matthew P. Mumber. Dr. Mumber regards integrative oncology as "the next step in the evolution of cancer care [including] the use of evidence based-tools [that] have their origin both in Western, conventional medicine and in complementary and alternative medicine (CAM) traditions." Mumber, a radiation oncologist from Rome, Georgia, completed the 2-year distance-learning Associate Fellowship in the Program in Integrative Medicine at the University of Arizona. Assembling a cadre of coauthors that includes a number of the faculty from the Arizona program, Mumber and his colleagues have created a truly comprehensive educational resource that will long be of value to the full array of practitioners caring for the body, mind, and spirits of patients with malignant disease. This evidence-based text will be of use to sophisticated patients, students, clinicians, and those interested in research possibilities in the emerging field.

As promised in the text's title, section I is devoted to principles, comprised of seven chapters dealing with principles of integrative oncology, clinical research and evidence, physician training in integrative medicine, the health of the healer, models of care, legal issues, and business assessment. These chapters contain useful pragmatic information and raise important issues that practitioners of integrative oncology at all levels need to comprehend. A description in the research chapter on the challenges to conducting randomized controlled trials in complementary and alternative medicine is particularly poignant: One cannot help but note later in the text that the levels of evidence supporting most of the recommendations are generally levels II-IV as opposed to being derived from well-controlled randomized controlled trials. This lack of level I evidence for CAM interventions also likely explains the lament of the pioneer integrative oncologist quoted in the business assessment chapter.

In my opinion, there is something deeply flawed about a healthcare system in which I, as an oncologist, can readily spend tens of thousands of dollars of Medicare funds to extend the life of an elderly man with advanced lung cancer for perhaps three or four months, utilizing expensive chemotherapy treatments, growth factors, blood transfusions, CT Scans, MRI Scans, and other costly diagnostic procedures…but I cannot find $100, or even $50 for an acupuncture treatment, a therapeutic massage, or a private counseling session for a frightened, terrified single mother of three children who is battling metastatic breast cancer—and who is sitting in the very next room.

Some useful tips for dealing with these sorts of frustrations are provided in the chapter entitled "The health of the healer: physician/health-care provider wellness." With burnout being an especially vexing problem in cancer care providers, we can all stand to review the contents of this well-written selection and take advantage of the final table's extensive listing of Web links to programs and activities to enhance personal wellness.

Section II provides the reader with information on the practice of clinical integrative oncology in an intricately woven way. Chapter 10 describes an overview of the eight modalities of intervention to be explored-physical activity, nutrition, mind-body interventions, botanicals, manual therapy, energy medicine, spirituality, and alternative medical systems (traditional Chinese medicine, Ayurveda, homeopathy)—in subchapters 10a through 10h. The author for each modality is responsible for the subchapters involving their area of expertise in the following chapters. Chapter 11 reviews the use of five of the above in cancer prevention, chapter 12 covers seven of the modalities in supportive care, and chapter 13 includes information regarding the use of four of the modalities in the actual treatment of cancer.

These chapters contain some very critical information and some truly outstanding tables that will serve as useful references for the practitioner of integrative oncology. For example, Table 11.5 in the nutrition subchapter of the prevention piece offers a comprehensive outline of phyto-chemicals and their proposed biologic mechanisms. The nutrition section of the next chapter also has a nice table on coping with treatment-related symptoms that alter diet. For anyone interested in obtaining a standardized accounting of dietary supplements their patients may be ingesting, Figure 12.1 offers an easy to reproduce form that will facilitate such data collection. Table 12.5 is another valuable resource—a compilation of recommended mind-body interventions for the relief of a number of symptoms with the level of evidence supporting the modality. The following table in the botanicals subchapter alerts us to possible herb interactions with chemotherapeutic agents possibly mediated via various cytochrome P450 isoforms—absolutely essential information for practitioners.

As if this interweaving of the modalities into chapters on prevention, supportive care, and antineoplastic therapy was not enough, chapter 15 looks again at the interventions and their use in a number of specific cancers including breast, prostate, lung, colorectal, and skin. Each of these chapters contains an elaborate table outlining the benefits of the modalities for primary, secondary, and tertiary prevention of each of the malignancies with the corresponding level of evidence for the intervention. Again, the absence of any real level I evidence in these tables should provide anyone interested in clinical investigation in integrative oncology with fertile soil for the development of research proposals.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Bladder Cancer Recurrence High, Better Follow-Up Care Needed
  • ASCO: Post-Surgery Surveillance Found Safe in Seminoma
  • Fertility Preservation in Women With Breast Cancer: Challenges and Opportunities
  • Addressing Fertility Concerns in Women Diagnosed With Breast Cancer: Will Serial Reserve Screening Help?
  • Postmenopausal Hormone Receptor–Positive Advanced Breast Cancer
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy